SeraCare's Seraseq Solid Tumor Mutation Mix-II Products

SeraCare Life Sciences has launched its Seraseq Solid Tumor Mutation Mix-II products. This includes eight new products that contain a total of 40 hard-to-sequence variants that  increases the number of insertion-deletion mutations from four to 13. Additionally, the products include two DNA-level structural variants of actionable gene fusions. The company is now providing a single-tube blended reference material format that contains all 40 variants in a tri-level configuration with mutations of 10 percent, seven percent, or four percent allelic frequencies, the company said.